Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eagle Pharmaceuticals (NQ: EGRX )

20.94 +0.48 (+2.35%)
Streaming Delayed Price Updated: 2:46 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 68,983
Open 20.36
Bid (Size) 20.88 (1)
Ask (Size) 20.95 (4)
Prev. Close 20.46
Today's Range 20.36 - 21.09
52wk Range 18.89 - 48.60
Shares Outstanding 12,698,566
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bluegreen Vacations, Eagle Pharmaceuticals And 3 Stocks To Watch Heading Into Monday
With US futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Why Fear Level Among US Investors Is Increasing
The CNN Money Fear and Greed index moved to the "Extreme Fear" zone following a sharp drop in the US stocks. Stocks on the Wall Street tumbled on Friday amid concerns over the U.S. regional banking... 
Via Benzinga

Performance

YTD
-28.36%
-28.36%
1 Month
-25.51%
-25.51%
3 Month
-25.21%
-25.21%
6 Month
-40.60%
-40.60%
1 Year
-55.16%
-55.16%

More News

Read More
Eagle Pharmaceuticals Earnings Preview
Via Benzinga
Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Recap: Eagle Pharmaceuticals Q3 Earnings
Via Benzinga
Enalare Secures BARDA Award Of $50M For ENA-001 In Drug Overdose
Via Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Via Benzinga
Eagle Pharma Broadens Acute Care Portfolio With Equity Stake In Respiratory Depression Player
Via Benzinga
Recap: Eagle Pharmaceuticals Q1 Earnings
Via Benzinga
Eagle Pharmaceuticals: Q2 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Perrigo Stock Mystery; Big Money Loves It, Though Profits Slim
Via Investor's Business Daily
Short Volatility Alert: Eagle Pharmaceuticals, Inc.
Via Benzinga
Eagle Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know
Via Benzinga
Eagle Pharma Adds Hospital-Based Products With €95M Acacia Pharma Deal
Via Benzinga
Eagle Pharma's Q4 Earnings Miss Street View On Lower Product Sales
Via Benzinga
Eagle Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For March 7, 2022
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Via Benzinga
Eagle Pharmaceuticals's Earnings Outlook
Via Benzinga
Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY™
From Eagle Pharmaceuticals, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.